Pharma Sector: Few Newsmakers Of The Week - Opexa, J&J, Glaxo ...
Trading Markets - Los Angeles,CA,USA
Opexa's lead product, Tovaxin, indicated for Multiple Sclerosis is also a T-cell-based therapeutic vaccine. Wednesday, Johnson & Johnson (JNJ | charts ...